LEISX | VIVIX | LEISX / VIVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 27 years | - |
Gain YTD | 1.372 | 0.788 | 174% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 5000000 | 20% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 736M | 184B | 0% |
Annual Yield % from dividends | 1.12 | 2.37 | 47% |
Returns for 1 year | 1.98 | 14.30 | 14% |
Returns for 3 years | -6.35 | 14.09 | -45% |
Returns for 5 years | 6.01 | 41.07 | 15% |
Returns for 10 years | 9.63 | 106.11 | 9% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LMVOX | 29.54 | 0.34 | +1.16% |
Lord Abbett Focused Small Cap Value F3 | |||
APSGX | 17.29 | 0.15 | +0.88% |
NYLI Fiera SMID Growth Class I | |||
FKASX | 47.27 | 0.36 | +0.77% |
Federated Hermes Kaufmann Small Cap A | |||
TOTRX | 10.80 | 0.06 | +0.56% |
Transamerica Mid Cap Value Opps R | |||
FINFX | 80.95 | 0.28 | +0.35% |
American Funds Fundamental Invs F2 |